Steward Partners Investment Advisory’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-4,500
Closed -$185K – 3223
2022
Q2
$185K Sell
4,500
-500
-10% -$24.3K ﹤0.01% 1231
2022
Q1
$290K Hold
5,000
– – ﹤0.01% 1154
2021
Q4
$294K Hold
5,000
– – ﹤0.01% 1149
2021
Q3
$304K Hold
5,000
– – 0.01% 1105
2021
Q2
$300K Buy
5,000
+4,500
+900% +$225K 0.01% 1187
2021
Q1
$23.6K Hold
500
– – ﹤0.01% 2395
2020
Q4
$19K Sell
500
-750
-60% -$24.7K ﹤0.01% 2070
2020
Q3
$41K Buy
1,250
+500
+67% +$21.2K ﹤0.01% 1582
2020
Q2
$34K Buy
+750
New +$38.3K ﹤0.01% 1566

Other funds holding ATEX

Steward Partners Investment Advisory's ATEX Position: Q3 2022 in Review

Steward Partners Investment Advisory sold out of Anterix (ATEX) in Q3 2022, closing a stake of 4,500 shares — an estimated $185K sold.

Steward Partners Investment Advisory first reported a position in ATEX in Q2 2020 and held it in 9 quarters. The position peaked at $304K in Q3 2021. 100 funds tracked by Wall St. Rank hold ATEX as of Q3 2022.

  • Steward Partners Investment Advisory reported no remaining Anterix position as of Q3 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 4,500 Anterix shares in Q3 2022, an estimated $185K.
  • Steward Partners Investment Advisory first reported a position in Anterix in Q2 2020 and held it in 9 quarters.
  • Steward Partners Investment Advisory's Anterix position peaked at $304K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Anterix as of Q3 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2022, filed 10 Nov 2022.